INVITROGEN EUROPE LIMITED
Get an alert when INVITROGEN EUROPE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2027-05-17 (in 1y)
Last made up 2026-05-03
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£23B
0% vs 2024
Employees
—
Average over period
Profit before tax
£260K
-15.3% vs 2024
Name history
Renamed 3 times since incorporation
- INVITROGEN EUROPE LIMITED 2001-05-04 → present
- LIFE TECHNOLOGIES OVERSEAS LIMITED 1990-01-16 → 2001-05-04
- GIBCO OVERSEAS LIMITED 1983-09-29 → 1990-01-16
- SALLOUT LIMITED 1983-08-17 → 1983-09-29
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£13,000 | -£14,000 | |
| Profit before tax | £307,000 | £260,000 | |
| Net profit | £307,000 | £260,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £22,763,275,000 | £22,763,535,000 | |
| Net assets | £22,763,275,000 | £22,763,535,000 | |
| Equity | £22,763,275,000 | £22,763,535,000 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Return on capital employed | -0.0% | -0.0% |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Mitchell Charlesworth (Audit) Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Thermo Fisher Scientific Inc. has indicated its intention to provide any necessary financial support to enable the company to continue in operational existence for the foreseeable future. To this extent, the directors have received a letter of support from Thermo Fisher Scientific Inc. confirming their financial support for a period of at least twelve months from when these financial statements are authorised for issue. Thus, the directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.”
Group structure
- INVITROGEN EUROPE LIMITED · parent
- Erie N2 LLC 100%
- Erie N2 UK Limited
- Erie N10 LLC
- Thermo Fisher Scientific Powder UK Holdings Limited
- Erie UK 4 Limited
- Thermo Fisher Scientific AU II Limited
- Erie Finance LLC
- Applied Biosystems International Inc
- Life Technologies Corporation
- Thermo Fisher Scientific Powder Finance LLC
- Thermo Fisher Scientific Powder Financing 2 LLC
- Affymetrix Inc
- Panomics LLC
- eBiosceince Ltd
- Bender MedSystems GmbH
- Affymetrix Japan K.K.
- USB Corporation
- Invitrogen Argentina SA
- Life Technologies Clinical Services Lab, Inc
- Thermo Fisher Scientific Colombia S.A.S.
- Compendia Bioscience, Inc
- Invitrogen BioServices India PVT Ltd
- Westover Scientific, Inc
- Invitrogen IP Holdings, Inc
- Combinati Incorporated
- Invitrogen Finance Corporation
- Kettlebrook Insurance Co Ltd 32.5%
- Ion Torren Systems, Inc
- CellzDirect, Inc
- Ambion Inc
- Molecular Probes, Inc
- STC Bio manufacturing, Inc
- Acoustic Cytometry Systems, Inc
- Matrix MicroScience, Inc
- BioTrove Corporation
- BioTrove International, Inc
- Thermo Fisher Scientific Life Technologies Israel Investment I Limited
- Thermo Fisher Scientific Life Technologies Israel Investment II Limited
- Thermo Fisher Israel Ltd
- Gold Cattle Standard Testing Labs, Inc
- Applied Biosystems LLC
- NewcoGen PE, LLC
- HyClone International Trade (Tianjin) Co Ltd
- Perbio Science, Inc.
Significant events
- “In 2018 the company was part of a global reorganisation in which it acquired 100% of the shareholding of Erie N2 LLC. In consideration of this shareholding the company transferred its other 100% subsidiary holdings in Life Technologies Corporation and Affymetrix Inc to Erie N2 UK Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 28 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2014-05-06 | — | — |
| AHMED, Syed Waqas | Director | 2020-03-23 | Nov 1979 | British |
| CAMERON, Euan Daney Ross | Director | 2018-10-31 | Mar 1976 | British |
| GREEN, Georgina Adams | Director | 2024-04-18 | Mar 1970 | British |
| SMITH, Anthony Hugh | Director | 2018-11-12 | May 1962 | American |
| STARR, Alison Jane | Director | 2024-04-18 | Jan 1977 | British |
Show 28 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARLOW, Philip John | Secretary | 2002-09-01 | 2006-05-08 |
| CONNOLLY, Henry Gerald | Secretary | 1992-06-30 | 1999-07-15 |
| GREGG, Rhona | Secretary | 2015-09-10 | 2026-03-31 |
| MACLEOD, Genoffir Maud | Secretary | 2006-05-08 | 2014-05-06 |
| MCKEAND, James Murchie | Secretary | — | 1992-06-30 |
| NOBLE, Derek | Secretary | 2000-01-05 | 2002-09-01 |
| WARD, Nicola Jane | Secretary | 2014-05-06 | 2014-12-18 |
| BRUST, Bernd | Director | 2004-09-01 | 2009-07-16 |
| CONNOLLY, Henry Gerald | Director | 1992-06-30 | 1999-07-15 |
| COUTTS, Thomas Mccallum | Director | — | 2000-06-14 |
| DEUITCH, Dianne Marie | Director | 2010-11-08 | 2012-08-27 |
| FAULKNER, Daryl Jay | Director | 2000-06-14 | 2002-09-01 |
| GRANT, Lucie Mary Katja | Director | 2014-05-06 | 2019-12-03 |
| GREENWAY, Monette Rose | Director | 2002-09-01 | 2004-09-01 |
| INCE, Nicholas | Director | 2015-09-10 | 2018-10-31 |
| LAMBERT, Susan Anne | Director | 2004-05-01 | 2010-03-22 |
| MCKEAND, James Murchie | Director | — | 1992-06-30 |
| NOBLE, Derek | Director | 2000-06-14 | 2004-05-01 |
| NORMAN, David John | Director | 2015-11-16 | 2024-04-18 |
| SMITH, David Harper | Director | 2010-07-16 | 2014-04-04 |
| SMITH, David Harper | Director | 2004-09-10 | 2005-05-01 |
| SOUTER, Thomas Ireland | Director | 2002-09-01 | 2010-11-01 |
| STOKES, Joseph Celment | Director | 1992-01-31 | 2000-06-14 |
| SUTHERLAND, Janet | Director | 2012-08-27 | 2018-11-09 |
| THOMPSON, John D | Director | — | 1992-01-31 |
| WHEELER, Kevin Neil | Director | 2014-05-06 | 2015-11-16 |
| WINZER, Carl Eric | Director | 2000-06-14 | 2002-09-01 |
| WRIGHT, Katie Rose | Director | 2014-05-06 | 2015-09-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Invitrogen Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 201 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-06 | AA | accounts | Accounts with accounts type full | |
| 2026-05-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-05-08 | AA | accounts | Accounts with accounts type full | |
| 2025-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-08 | AA | accounts | Accounts with accounts type full | |
| 2024-04-23 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-17 | AA | accounts | Accounts with accounts type full | |
| 2023-05-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-27 | SH01 | capital | Capital allotment shares | |
| 2022-05-17 | AA | accounts | Accounts with accounts type full | |
| 2022-05-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-01-26 | SH01 | capital | Capital allotment shares | |
| 2021-10-11 | AA | accounts | Accounts with accounts type full | |
| 2021-05-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-01-12 | SH01 | capital | Capital allotment shares | |
| 2020-12-16 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
0%
£22,763,275,000 £22,763,535,000
-
Employees
—
Not reported
-
Operating profit
-7.7%
-£13,000 -£14,000
-
Profit before tax
-15.3%
£307,000 £260,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers